XORTX Therapeutics, Inc. (XRTX)
2.25
-0.03
(-1.32%)
USD |
NASDAQ |
Sep 09, 10:55
XORTX Therapeutics Total Liabilities (Quarterly) : 0.6795M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.6795M |
| March 31, 2026 | 0.861M |
| December 31, 2025 | 0.5991M |
| September 30, 2025 | 0.8374M |
| June 30, 2025 | 0.7115M |
| March 31, 2025 | 0.7574M |
| December 31, 2024 | 0.758M |
| September 30, 2024 | 1.717M |
| June 30, 2024 | 2.095M |
| March 31, 2024 | 3.560M |
| December 31, 2023 | 0.8259M |
| September 30, 2023 | 0.5538M |
| June 30, 2023 | 0.4033M |
| March 31, 2023 | 0.5998M |
| December 31, 2022 | 5.378M |
| September 30, 2022 | 3.096M |
| June 30, 2022 | 2.947M |
| Date | Value |
|---|---|
| March 31, 2022 | 4.036M |
| December 31, 2021 | 4.194M |
| September 30, 2021 | 9.529M |
| June 30, 2021 | 3.241M |
| March 31, 2021 | 3.800M |
| December 31, 2020 | 0.8118M |
| September 30, 2020 | 0.7445M |
| June 30, 2020 | 0.6394M |
| March 31, 2020 | 0.822M |
| December 31, 2019 | 1.002M |
| September 30, 2019 | 0.8889M |
| June 30, 2019 | 0.816M |
| March 31, 2019 | 0.723M |
| December 31, 2018 | 0.691M |
| September 30, 2018 | 0.6937M |
| June 30, 2018 | 0.63M |
| March 31, 2018 | 0.6375M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | 0.4371M |
| InMed Pharmaceuticals, Inc. | 2.242M |
| Target Group, Inc. (Canada) | 14.33M |
| NervGen Pharma Corp. | 51.39M |
| Milestone Pharmaceuticals, Inc. | 163.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.184M |
| Shareholders Equity (Quarterly) | 5.505M |
| Current Ratio | 3.586 |
| Net Debt Paydown Yield | 0.08% |